In this lunch talk, Prof. Dr. med. Welge-Lüssen discusses the significant patient burden caused by vitreous floaters and introduces VitroCap®N as a non-invasive treatment option. He presents the scientific rationale behind micronutrient therapy, reviews clinical evidence—including results from the FLIES study—and shares insights from more than ten years of clinical experience using VitroCap®N in practice.
Here you will first find a 3-minute highlight video. If you scroll further down, the table of contents will lead you to the recordings of the complete presentation.
*If subtitles do not appear automatically, please enable them using the subtitles icon left of the settings (gear) icon in the bottom-right corner of the video player.
Talk overview (time stamps):
Professor Ulrich-Christoph Welge-Lüssen studied medicine at the University of Würzburg and Ludwig Maximilian University of Munich (LMU), graduating in 1994. He completed his MD in 1997 with a thesis on collagen IV gene silencers, followed by his habilitation in 2004, focusing on the role of TGF-β in ocular pathologies.
In January 2008, he was appointed Professor of Ophthalmology at the Department of Ophthalmology of Friedrich-Alexander University Erlangen-Nürnberg, under the leadership of Professor Dr. F. Kruse. During his academic career, including his time at the Eye Clinic of LMU Munich, he led the corneal bank and the molecular cell biology research group.
His scientific work focused on scarring processes, oxidative stress in the pathogenesis of eye diseases, and glaucoma research, particularly vascular aspects beyond intraocular pressure. For these contributions, Professor Welge-Lüssen has received numerous prestigious awards, including the German Glaucoma Researcher Prize, multiple DOG Research Awards, the European Eye Bank Association Prize, and the International MSD Award.
Since 2018, he has been leading four ophthalmology practices in and around Munich, including his private practice at Brienner Straße 3. Today, his clinical work is primarily surgical, with a strong focus on refractive and cataract surgery, intravitreal therapies (IVOM) for AMD, retinal diseases such as epiretinal gliosis, and glaucoma surgery including stents and trabeculectomy.
Professor Welge-Lüssen is an active member of the German Ophthalmological Society (DOG), EVER, ARVO, the German Society for Connective Tissue Research, and the Brain and Ocular Nutrition Conference (BON). He also serves as a reviewer for leading journals such as Investigative Ophthalmology & Visual Science, Experimental Eye Research, and Current Eye Research, and collaborates internationally, including with the Nutritional Research Centre Ireland in Waterford.
Building on his long-standing expertise in oxidative damage, collagen biology, connective tissue, and ocular nutrition, Professor Welge-Lüssen has transitioned into pioneering research on non-invasive treatments for vitreous floaters. This work culminated in the FLIES trial, co-authored in 2021, investigating micronutrient-based therapeutic approaches.
Prof. Dr. med Welge-Lüssen
This content is intended solely for the eyes of healthcare professionals. Please confirm below:
